Results for "Understanding Pharmaceutical Distribution"
Specialty Distributors Serve a Range of Healthcare Providers
New benchmarking data released today by the HDA Research Foundation reveal the continued efficiency and reliability that HDA specialty distributors deliver to providers treating patients with chronic, complex or rare diseases. As illustrated in the 14th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, a typical HDA-member specialty distributor delivered products to approximately 56,000 provider ship-to points daily in 2021.
Specialty Distributors Continue To Provide Effective Delivery and Value to the U.S. Healthcare Ecosystem
New benchmarking data released by the HDA Research Foundation showcase the continued value of HDA specialty distributors to the U.S. healthcare ecosystem. As illustrated in the 15th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, the average specialty distributor delivered medicines to treat chronic, complex or rare diseases to 51,469 unique ship-to points in 2022.
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.
HDA Presents 2023 Distribution Management Award to Spherity and Legisym
The Healthcare Distribution Alliance (HDA) honored Spherity and Legisym with the 2023 Distribution Management Award (DMA) in recognition of the companies’ work on a credentialing solution for Drug Supply Chain Security Act (DSCSA) Authorized Trading Partner (ATP) authentication. The award was presented during the 2023 Distribution Management Conference and Expo in Indianapolis.